![]() | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
| "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2019-09-16 Purchase | 2019-09-17 5:27 pm | LEXICON PHARMACEUTICALS Inc | LXRX | SOBECKI CHRISTOPHER J Director | 25,000 | $2.5487 | $63,718 | 137,293 (Direct) | View |
2019-09-13 Purchase | 2019-09-17 5:33 pm | LEXICON PHARMACEUTICALS Inc | LXRX | DEBBANE RAYMOND Director | 197,473 | $2.4042 | $474,760 | 210,375 (Indirect Direct) | View |
2019-09-13 Purchase | 2019-09-17 5:36 pm | LEXICON PHARMACEUTICALS Inc | LXRX | DEBBANE RAYMOND Director | 103,042 | $2.694 | $277,591 | 313,417 (Indirect Direct) | View |
2019-09-17 Purchase | 2019-09-18 4:39 pm | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 50,000 | $3.1281 | $156,403 | 177,539 (Direct) | View |
2019-09-18 Purchase | 2019-09-19 4:26 pm | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 4,500 | $3.3589 | $15,115 | 18,661 (Direct) | View |
2019-09-18 Purchase | 2019-09-19 4:28 pm | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 50,000 | $3.1 | $155,000 | 227,539 (Direct) | View |
2020-12-16 Purchase | 2020-12-17 2:39 pm | LEXICON PHARMACEUTICALS Inc | LXRX | Invus Public Equities L.P. Artal Treasury Ltd Invus L.P. Invus Public Equities Advisors LLC Invus Advisors L.L.C. Director 10% Owner | 10,937,500 | $3.2 | $35,000,001 | 32,259,460 (Indirect) | View |
2020-12-16 Purchase | 2020-12-17 2:43 pm | LEXICON PHARMACEUTICALS Inc | LXRX | Artal International S.C.A. Minne Pascal Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Director 10% Owner | 10,937,500 | $3.2 | $35,000,001 | 32,259,460 (Indirect) | View |
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2020-02-06 Option Award | 2020-02-10 4:06 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 253,890 | $0 | 761,660 (Direct) | View |
2020-02-06 Option Award | 2020-02-10 4:06 pm | N/A 2030-02-06 | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 761,660 | $3.31 | 761,660 (Direct) | View |
2020-02-06 Option Award | 2020-02-10 4:07 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 82,410 | $0 | 247,220 (Direct) | View |
2020-02-06 Option Award | 2020-02-10 4:07 pm | N/A 2030-02-06 | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 247,220 | $3.31 | 247,220 (Direct) | View |
2020-02-06 Option Award | 2020-02-10 4:10 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Crum Brian T VP | 63,090 | $0 | 189,260 (Direct) | View |
2020-02-06 Option Award | 2020-02-10 4:10 pm | N/A 2030-02-06 | LEXICON PHARMACEUTICALS Inc | LXRX | Crum Brian T VP | 189,260 | $3.31 | 189,260 (Direct) | View |
2020-02-06 Option Award | 2020-02-10 4:12 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 70,560 | $0 | 211,690 (Direct) | View |
2020-02-06 Option Award | 2020-02-10 4:12 pm | N/A 2030-02-06 | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 211,690 | $3.31 | 211,690 (Direct) | View |
2020-02-06 Option Award | 2020-02-10 4:13 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 69,900 | $0 | 209,700 (Direct) | View |
2020-02-06 Option Award | 2020-02-10 4:13 pm | N/A 2030-02-06 | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 209,700 | $3.31 | 209,700 (Direct) | View |
2020-02-06 Option Award | 2020-02-10 4:14 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | TYLE PRAVEEN VP | 86,070 | $0 | 258,210 (Direct) | View |
2020-02-06 Option Award | 2020-02-10 4:14 pm | N/A 2030-02-06 | LEXICON PHARMACEUTICALS Inc | LXRX | TYLE PRAVEEN VP | 258,210 | $3.31 | 258,210 (Direct) | View |
2020-02-06 Option Award | 2020-02-10 4:15 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 41,990 | $0 | 62,980 (Direct) | View |
2020-02-06 Option Award | 2020-02-10 4:15 pm | N/A 2030-02-06 | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 62,980 | $3.31 | 62,980 (Direct) | View |
2020-02-06 Option Award | 2020-02-10 4:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 91,400 | $0 | 274,200 (Direct) | View |
2020-02-06 Option Award | 2020-02-10 4:18 pm | N/A 2030-02-06 | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 274,200 | $3.31 | 274,200 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:11 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 8,390 | $0 | 158,760 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:11 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 5,363 | $0 | 158,760 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:11 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 23,514 | $0 | 158,760 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:11 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 79,380 | $0 | 158,760 (Direct) | View |
2020-02-28 Tax Withholding | 2020-03-03 4:11 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 45,320 | $2.77 | 158,760 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:11 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 8,390 | $0 | 158,760 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:11 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 5,363 | $0 | 158,760 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:11 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 23,514 | $0 | 158,760 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:11 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | COATS LONNEL CEO | 79,380 | $0 | 158,760 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:12 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Crum Brian T VP | 2,515 | $0 | 22,200 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:12 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Crum Brian T VP | 1,518 | $0 | 22,200 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:12 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Crum Brian T VP | 5,119 | $0 | 22,200 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:12 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Crum Brian T VP | 11,100 | $0 | 22,200 (Direct) | View |
2020-02-28 Tax Withholding | 2020-03-03 4:12 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Crum Brian T VP | 6,940 | $2.77 | 22,200 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:12 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Crum Brian T VP | 2,515 | $0 | 22,200 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:12 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Crum Brian T VP | 1,518 | $0 | 22,200 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:12 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Crum Brian T VP | 5,119 | $0 | 22,200 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:12 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Crum Brian T VP | 11,100 | $0 | 22,200 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:13 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 4,085 | $0 | 44,747 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:13 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 2,498 | $0 | 44,747 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:13 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 8,296 | $0 | 44,747 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:13 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 22,373 | $0 | 44,747 (Direct) | View |
2020-02-28 Tax Withholding | 2020-03-03 4:13 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 12,759 | $2.77 | 44,747 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:13 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 4,085 | $0 | 44,747 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:13 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 2,498 | $0 | 44,747 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:13 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 8,296 | $0 | 44,747 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:13 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 22,373 | $0 | 44,747 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:15 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 4,228 | $0 | 46,927 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:15 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 2,585 | $0 | 46,927 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:15 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 8,570 | $0 | 46,927 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:15 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 23,463 | $0 | 46,927 (Direct) | View |
2020-02-28 Tax Withholding | 2020-03-03 4:15 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 13,305 | $2.77 | 46,927 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:15 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 4,228 | $0 | 46,927 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:15 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 2,585 | $0 | 46,927 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:15 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 8,570 | $0 | 46,927 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:15 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 23,463 | $0 | 46,927 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:16 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 2,353 | $0 | 45,707 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:16 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 2,593 | $0 | 45,707 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:16 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 8,464 | $0 | 45,707 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:16 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 22,853 | $0 | 45,707 (Direct) | View |
2020-02-28 Tax Withholding | 2020-03-03 4:16 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 12,420 | $2.77 | 45,707 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:16 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 2,353 | $0 | 45,707 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:16 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 2,593 | $0 | 45,707 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:16 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 8,464 | $0 | 45,707 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:16 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 22,853 | $0 | 45,707 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 2,075 | $0 | 17,673 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 1,270 | $0 | 17,673 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 4,214 | $0 | 17,673 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 8,837 | $0 | 17,673 (Direct) | View |
2020-02-28 Tax Withholding | 2020-03-03 4:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 3,902 | $2.77 | 17,673 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 2,075 | $0 | 17,673 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 1,270 | $0 | 17,673 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 4,214 | $0 | 17,673 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 8,837 | $0 | 17,673 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | TYLE PRAVEEN VP | 2,990 | $0 | 53,200 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | TYLE PRAVEEN VP | 9,726 | $0 | 53,200 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | TYLE PRAVEEN VP | 26,600 | $0 | 53,200 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | TYLE PRAVEEN VP | 2,990 | $0 | 53,200 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | TYLE PRAVEEN VP | 9,726 | $0 | 53,200 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:17 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | TYLE PRAVEEN VP | 26,600 | $0 | 53,200 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 4,495 | $0 | 50,580 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 2,798 | $0 | 50,580 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 9,555 | $0 | 50,580 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 25,290 | $0 | 50,580 (Direct) | View |
2020-02-28 Tax Withholding | 2020-03-03 4:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 16,025 | $2.77 | 50,580 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 4,495 | $0 | 50,580 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 2,798 | $0 | 50,580 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 9,555 | $0 | 50,580 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:18 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 25,290 | $0 | 50,580 (Direct) | View |
2020-04-22 Option Award | 2020-04-24 5:02 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 19,893 | $0 | 85,719 (Direct) | View |
2020-04-22 Tax Withholding | 2020-04-24 5:02 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Lapuerta Pablo EVP and CMO | 6,813 | $1.96 | 85,719 (Direct) | View |
2020-04-22 Option Award | 2020-04-24 5:05 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Crum Brian T VP | 19,893 | $0 | 49,732 (Direct) | View |
2020-04-22 Tax Withholding | 2020-04-24 5:05 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Crum Brian T VP | 6,398 | $1.96 | 49,732 (Direct) | View |
2020-04-22 Option Award | 2020-04-24 5:08 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 19,893 | $0 | 104,640 (Direct) | View |
2020-04-22 Tax Withholding | 2020-04-24 5:08 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | MAIN ALAN J VP | 6,813 | $1.96 | 104,640 (Direct) | View |
2020-04-22 Option Award | 2020-04-24 5:12 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 19,893 | $0 | 55,584 (Direct) | View |
2020-04-22 Tax Withholding | 2020-04-24 5:12 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Santini Alexander A EVP and CCO | 6,813 | $1.96 | 55,584 (Direct) | View |
2020-04-22 Option Award | 2020-04-24 5:15 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 13,262 | $0 | 65,127 (Direct) | View |
2020-04-22 Tax Withholding | 2020-04-24 5:15 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Tessmer James F VP | 3,997 | $1.96 | 65,127 (Direct) | View |
2020-04-22 Option Award | 2020-04-24 5:20 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | TYLE PRAVEEN VP | 19,893 | $0 | 69,344 (Direct) | View |
2020-04-22 Tax Withholding | 2020-04-24 5:20 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | TYLE PRAVEEN VP | 4,844 | $1.96 | 69,344 (Direct) | View |
2020-04-22 Option Award | 2020-04-24 5:24 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 26,525 | $0 | 115,495 (Direct) | View |
2020-04-22 Tax Withholding | 2020-04-24 5:24 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | WADE JEFFREY L CFO | 9,651 | $1.96 | 115,495 (Direct) | View |
2020-04-24 Exercise | 2020-04-27 4:43 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Amouyal Philippe Director | 3,466 | $0 | 0 (Direct) | View |
2020-04-24 Option Award | 2020-04-27 4:43 pm | N/A 2030-04-24 | LEXICON PHARMACEUTICALS Inc | LXRX | Amouyal Philippe Director | 18,115 | $1.86 | 0 (Direct) | View |
2020-04-24 Option Award | 2020-04-27 4:43 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Amouyal Philippe Director | 10,638 | $0 | 0 (Direct) | View |
2020-04-24 Exercise | 2020-04-27 4:43 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Amouyal Philippe Director | 3,466 | $0 | 0 (Direct) | View |
2020-04-24 Exercise | 2020-04-27 4:44 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | BARKER SAM L Director | 3,466 | $0 | 0 (Direct) | View |
2020-04-24 Option Award | 2020-04-27 4:44 pm | N/A 2030-04-24 | LEXICON PHARMACEUTICALS Inc | LXRX | BARKER SAM L Director | 18,115 | $1.86 | 0 (Direct) | View |
2020-04-24 Option Award | 2020-04-27 4:44 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | BARKER SAM L Director | 10,638 | $0 | 0 (Direct) | View |
2020-04-24 Exercise | 2020-04-27 4:44 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | BARKER SAM L Director | 3,466 | $0 | 0 (Direct) | View |
2020-04-24 Exercise | 2020-04-27 4:45 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | DEBBANE RAYMOND Director | 3,466 | $0 | 0 (Direct) | View |
2020-04-24 Option Award | 2020-04-27 4:45 pm | N/A 2030-04-24 | LEXICON PHARMACEUTICALS Inc | LXRX | DEBBANE RAYMOND Director | 18,115 | $1.86 | 0 (Direct) | View |
2020-04-24 Option Award | 2020-04-27 4:45 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | DEBBANE RAYMOND Director | 10,638 | $0 | 0 (Direct) | View |
2020-04-24 Exercise | 2020-04-27 4:45 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | DEBBANE RAYMOND Director | 3,466 | $0 | 0 (Direct) | View |
2020-04-24 Exercise | 2020-04-27 4:46 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | LEFKOWITZ ROBERT J MD Director | 3,466 | $0 | 0 (Direct) | View |
2020-04-24 Option Award | 2020-04-27 4:46 pm | N/A 2030-04-24 | LEXICON PHARMACEUTICALS Inc | LXRX | LEFKOWITZ ROBERT J MD Director | 18,115 | $1.86 | 0 (Direct) | View |
2020-04-24 Option Award | 2020-04-27 4:46 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | LEFKOWITZ ROBERT J MD Director | 10,638 | $0 | 0 (Direct) | View |
2020-04-24 Exercise | 2020-04-27 4:46 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | LEFKOWITZ ROBERT J MD Director | 3,466 | $0 | 0 (Direct) | View |
2020-04-24 Exercise | 2020-04-27 4:47 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | NIES ALAN S Director | 3,466 | $0 | 0 (Direct) | View |
2020-04-24 Option Award | 2020-04-27 4:47 pm | N/A 2030-04-24 | LEXICON PHARMACEUTICALS Inc | LXRX | NIES ALAN S Director | 18,115 | $1.86 | 0 (Direct) | View |
2020-04-24 Option Award | 2020-04-27 4:47 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | NIES ALAN S Director | 10,638 | $0 | 0 (Direct) | View |
2020-04-24 Exercise | 2020-04-27 4:47 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | NIES ALAN S Director | 3,466 | $0 | 0 (Direct) | View |
2020-04-24 Exercise | 2020-04-27 4:48 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Palantoni Frank Director | 3,466 | $0 | 0 (Direct) | View |
2020-04-24 Option Award | 2020-04-27 4:48 pm | N/A 2030-04-24 | LEXICON PHARMACEUTICALS Inc | LXRX | Palantoni Frank Director | 18,115 | $1.86 | 0 (Direct) | View |
2020-04-24 Option Award | 2020-04-27 4:48 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Palantoni Frank Director | 10,638 | $0 | 0 (Direct) | View |
2020-04-24 Exercise | 2020-04-27 4:48 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Palantoni Frank Director | 3,466 | $0 | 0 (Direct) | View |
2020-04-24 Exercise | 2020-04-27 4:48 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | SOBECKI CHRISTOPHER J Director | 3,466 | $0 | 0 (Direct) | View |
2020-04-24 Option Award | 2020-04-27 4:48 pm | N/A 2030-04-24 | LEXICON PHARMACEUTICALS Inc | LXRX | SOBECKI CHRISTOPHER J Director | 18,115 | $1.86 | 0 (Direct) | View |
2020-04-24 Option Award | 2020-04-27 4:48 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | SOBECKI CHRISTOPHER J Director | 10,638 | $0 | 0 (Direct) | View |
2020-04-24 Exercise | 2020-04-27 4:48 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | SOBECKI CHRISTOPHER J Director | 3,466 | $0 | 0 (Direct) | View |
2020-04-24 Exercise | 2020-04-27 4:49 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Swain Judith L Director | 3,466 | $0 | 0 (Direct) | View |
2020-04-24 Option Award | 2020-04-27 4:49 pm | N/A 2030-04-24 | LEXICON PHARMACEUTICALS Inc | LXRX | Swain Judith L Director | 18,115 | $1.86 | 0 (Direct) | View |
2020-04-24 Option Award | 2020-04-27 4:49 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Swain Judith L Director | 10,638 | $0 | 0 (Direct) | View |
2020-04-24 Exercise | 2020-04-27 4:49 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Swain Judith L Director | 3,466 | $0 | 0 (Direct) | View |
2020-12-31 Other | 2021-01-05 9:21 pm | N/A N/A | LEXICON PHARMACEUTICALS Inc | LXRX | Invus C.V. Director 10% Owner | 4,321,214 | $0 | 0 (Direct) | View |